FDA approves Ozempic to treat CKD in diabetes patients; AbbVie, Neomorph ink US$ 1.64 bn deal for molecular glue degraders
Novo Nordisk’s Ozempic became the first glucagon-like peptide 1 (GLP-1) drug to receive the US Food and Drug Administrati...
Impressions : 1326
Takeda eyes Shire, may pay over US$ 50 billion; FDA to speed up approval of biosimilars
This week, Phispers brings you news on Japanese drugmaker Takeda, which has shown interest in buying Irish pharma company Shire...
Impressions : 3227
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.